The Hisense CAS (ComputerAssisted Surgery Computer Aided Surgery) surgical system developed by Qingdao Hisense Medical Equipment Co., Ltd. (hereinafter referred to as “Hisense Medical Equipmentâ€) has been active in a famous children's hospital in Shanghai for a pair of conjoined baby infants in the middle of this month. The successful implementation of the effective separation surgery has created a precedent for the successful separation of conjoined infant cases using computer-aided systems in the country. This is the message from Hisense Medical Equipment held a press conference in Shanghai about Hisense's precision medical technology for surgery. The medical electronic consumer market has huge space With the continuous population growth, the aging of society and the growing awareness of human health, the proportion of medical expenditure to GDP has been relatively high in developed countries. The current proportion of the United States is close to 18%, while the proportion of China's mainland is only 5.4. % shows that China's healthcare industry has huge growth potential. With the continuous growth of the global medical electronics consumer market demand, the contemporary medical electronics industry with a series of advantages such as informationization, networking and portability has been steadily expanding with the new medical models such as mobile medical , smart medical and telemedicine. Growth stage. Data show that global market sales in 2014 were approximately $225.5 billion, an increase of 5.67% year-on-year. Professional medical electronics companies in Europe, the United States and Japan, such as Johnson & Johnson, Medtronic, Boston Science, Philips, etc., even traditional consumer electronics giants such as GE, Siemens, Samsung, Sony, Canon, Toshiba and NEC have also nuggets In the medical electronics market, US, Europe and Japan medical electronics companies accounted for 85% of global medical electronics output in 2014. In recent years, the demand for medical electronics in mainland China has also grown, becoming the world's third largest medical electronics market (after the United States and Japan). Data show that in 2014, China's medical electronics market sales of 19.18 billion US dollars, an increase of 22.6%. Relevant research institutions believe that, thanks to favorable factors such as the country's increasing emphasis on the construction of the whole society's medical service system, the average annual compound growth rate of China's medical electronics market will reach 25% in the next few years. Despite this, a paradox is that domestic medical equipment only occupies the low-end market, and the high-end medical electronic equipment market has been monopolized by foreign brands. For example, more than 75% of high-end medical imaging equipment such as CT and MRI are “GPSâ€. (GE, Philips and Siemens three companies collectively) occupied. However, some experts expect that as China's medical equipment localization policy continues to fall, and in recent years, domestic medical electronics companies have broken through many key technologies, the share of domestic medical electronic equipment in the high-end medical electronics market is expected to usher in the next two years. Attack. It is understood that the relevant state ministries and commissions have issued a series of documents and policies to encourage and support the development of mobile medical care. Among them, the Ministry of Industry and Information Technology and the Ministry of Science and Technology have included personal medical monitoring and remote diagnosis in the development priorities of the five-year plan, and provided corresponding funding. The Ministry of Health has also initiated and sponsored mobile medical demonstration projects within the Cooperative Medical Services Demonstration Project, including mobile medical solutions such as case records, disease data and health quality monitoring. Accurate medical effects have been remarkable A series of new medical tools, such as mobile medical, smart medical and telemedicine, are based on how to implement them through precision medicine. The popular traditional medicine is based on evidence-based medicine, which relies mainly on the clinical practice and experience of clinicians to achieve diagnosis and treatment. In contrast, precision medicine pays attention to how to determine the physical characteristics and disease types of each patient, through the analysis of gene sequencing data, to obtain diagnosis and treatment plans for disease subjects, and to implement precise treatment. To be precise, precision medicine, as a new generation of diagnosis and treatment technology, is the application of modern genetic technology, molecular imaging technology and bioinformatics technology, combined with the patient's living environment and clinical data, to achieve accurate disease classification and diagnosis, and to develop personalized prevention and prevention. Treatment programs. According to estimates by the American Medical Research Institute, the country's medical system wastes about $750 billion annually due to unnecessary treatment and ineffective treatment, equivalent to 30% of total medical expenses. In China, this kind of invalid medical expenses is undoubtedly more serious. Therefore, it has become a major choice for the international community today to reduce the huge medical expenses through accurate medical treatment while reducing the suffering of patients. As early as the end of the last century, the United States began to appear some unitary precision medical equipment. By the year 2000, the Da Vinci surgical system was born as a pioneer in modern robotic surgery systems. In 2011, the American medical community first proposed the concept of precision medicine. In early 2015, President Obama stated in his State of the Union speech that he would implement the “Accurate Medicine Program†and proposed to invest $215 million in the fiscal year 2016 to promote personalized medical development. The relevant departments of our country also attach great importance to promoting the development of precision medical industry. Accurate medical care has been included in China's "13th Five-Year Plan" for the study of health security development issues, and plans to invest 60 billion yuan by 2030. In February 2015, according to the relevant instructions of General Secretary Xi Jinping, the Ministry of Science and Technology and the National Health and Family Planning Commission led the establishment of a national expert committee on precision medical strategy composed of 19 experts. Previously, the news from the National Health and Family Planning Commission indicated that the “precise medical†strategic plan currently being developed in China will be included in the 13th Five-Year Major Science and Technology Project. Experts say that precision medicine will change the existing diagnostic and treatment models and will bring about a revolution in the development of modern medicine. Healthcare Products
The quality of raw materials for health care products should be taken seriously, including the production process, raw materials, and production technology of health care products, all of which must be strictly controlled. When selecting raw material suppliers, health care product manufacturers should Equipment and product quality are strictly inspected and investigated to avoid problems. Our Xi'an Hengruikang Biotechnology Co., Ltd. has been established for 20 years, specializing in the production and supply of raw materials, and has relevant qualifications and supporting facilities. Sound production equipment and professional production personnel. Our main products are: Improve Immunity , Healthcare Product ,Sex Enhancement Powder, Loss Weight ,Anti-hair Loss Powder,Immunity enhancement, Develop immunity ,Strong immune system.
Healthcare Products,Meloxicam Powder,Anti-Hair Loss Minoxidil Powder,Tetracaine Ophthalmic Solution Xi'an Henrikang Biotech Co.,Ltd , https://www.xianhenrikangbio.com